A detailed history of Schonfeld Strategic Advisors LLC transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 461,926 shares of OLMA stock, worth $2.91 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
461,926
Previous 116,926 295.06%
Holding current value
$2.91 Million
Previous $1.27 Million 335.97%
% of portfolio
0.04%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.41 - $16.46 $3.59 Million - $5.68 Million
345,000 Added 295.06%
461,926 $5.52 Million
Q2 2024

Aug 14, 2024

SELL
$8.73 - $13.99 $758,628 - $1.22 Million
-86,899 Reduced 42.63%
116,926 $1.27 Million
Q1 2024

May 15, 2024

BUY
$10.95 - $16.62 $2.23 Million - $3.39 Million
203,825 New
203,825 $2.31 Million
Q3 2023

Nov 14, 2023

SELL
$8.19 - $12.98 $436,060 - $691,094
-53,243 Reduced 42.39%
72,369 $893,000
Q2 2023

Aug 14, 2023

BUY
$3.22 - $9.65 $404,470 - $1.21 Million
125,612 New
125,612 $1.13 Million
Q3 2022

Nov 14, 2022

SELL
$2.72 - $5.88 $46,784 - $101,136
-17,200 Reduced 53.92%
14,700 $40,000
Q2 2022

Aug 15, 2022

SELL
$2.04 - $4.61 $29,172 - $65,923
-14,300 Reduced 30.95%
31,900 $130,000
Q1 2022

May 16, 2022

BUY
$3.89 - $9.43 $179,718 - $435,666
46,200 New
46,200 $197,000

Others Institutions Holding OLMA

About Olema Pharmaceuticals, Inc.


  • Ticker OLMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,419,600
  • Market Cap $255M
  • Description
  • Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...
More about OLMA
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.